Download PDF
Thromb Haemost 1995; 74(01): 511-514
DOI: 10.1055/s-0038-1642730
Symposium
Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment
Schattauer GmbH Stuttgart

Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment. Instrumentation and Methodology

Tizsano Barbui
Hematology Division, Ospedaii Riuniti, Bergamo, Italy
,
Guido Finazzi
Hematology Division, Ospedaii Riuniti, Bergamo, Italy
,
Andrea Remuzzi
Mario Negri Institute, Bergamo, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-75
    CrossrefPubMedGoogle Scholar
  • 2 Ansell JE. Oral anticoagulant therapy-50 years later. Arch Intern Med 1993; 153: 586-596
    CrossrefPubMedGoogle Scholar
  • 3 British Society for Haematology. Guidelines on oral anticoagulation: second edition. J Clin Pathol. 1990; 43: 177-183
    PubMedGoogle Scholar
  • 4 Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH. Risk factor for complications of chronic anticoagulation. A multicenter study. Ann Intern Med 1993; 118: 511-20
    CrossrefPubMedGoogle Scholar
  • 5 WHO Expert Committee on Biological Standardization. 31st Report. WHO Tech Ser 1981; 658: 185-205
    PubMedGoogle Scholar
  • 6 Poller L, Tabemer DA, Thomson JM, Darby KV. Survey of prothrombin time results in National External Quality Assessment Scheme exercises 1980-87. J Clin Pathol 1988; 41: 361-4
    CrossrefPubMedGoogle Scholar
  • 7 Brophy MT, Fiore LD, Lau J, Goodwin R, Lopez A, Deykin D. Comparison ofa standard and a sensitive thromboplastin in monitoring low intensity oral anticoagulant therapy. Am J Clin Pathol 1994; 102: 134-137
    CrossrefPubMedGoogle Scholar
  • 8 Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, Hawkins P, Peng M, Pelzer H, Teijdor LM, Ramirez IF, Kolde HJ. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemostas 1994; 71: 292-299
    PubMedGoogle Scholar
  • 9 Finazzi G, Falanga A, Galli M, Cortelazzo S, Remuzzi A, Barbui T. Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulation. Thromb Haemostas 1994; 72: 804-807
    PubMedGoogle Scholar
  • 10 Eckman MH, Levine HI, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993; 329: 696-702
    CrossrefPubMedGoogle Scholar
  • 11 Kitchen S, Walker ID, Woods TAL. Preston. Thromboplastin related differences in the determination of International Normalised Ratio: a cause for concern . Thromb Haemostas 1994; 72: 426-429
    PubMedGoogle Scholar
  • 12 Becker DM, Humphries JE, Walker FB, DeMong LK, Bopp JS, Acker MN. Standardizing the prothrombin time:calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993; 117: 602-605
    PubMedGoogle Scholar
  • 13 Cunningham M, Johnson GF, Pennell BJ, Olson JD. The reliability of manufactuter-determined, instrument-specific international sensitivity index for calculating the international normalized ratio. Am J Qin Pathol 1994; 102: 128-133
    PubMedGoogle Scholar
  • 14 Van Dijk-Wierda CA, Loeliger EA, Meilof J, Roos J. Anticoagulant control in the Netherlands. Lancet 1981; 1: 1321-1322
    PubMedGoogle Scholar
  • 15 Kumar S, Haigh JRM, Rhodes LE, Peaker S, Davies JA, Roberts BE, Feely MP. Poor compliance is a major factor in unstable outpatients control of anticoagulant therapy. Thromb Haemostas 1989; 62: 729-732
    PubMedGoogle Scholar
  • 16 Van den Besselaar AMHP, Van der Meer FJM, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-690
    CrossrefPubMedGoogle Scholar
  • 17 Azar AJ, Deckers JW, Rosendaal FR, Van Bergen PFMM, Van der Meer FJM, Janker JJC, Briet E. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemostas 1994; 72: 347-351
    PubMedGoogle Scholar
  • 18 Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications inpatients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641
    CrossrefPubMedGoogle Scholar
  • 19 Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostas 1993; 69: 316-320
    PubMedGoogle Scholar
  • 20 Taylor F, Ramsay M, Covell B, Gaminara L, Them son D, Cohen H, Voke J. Management of expanding anticoagulant clinics: a role for general practitioners. Br J Haematol 1994; 86 (01) 68 Abstract
    PubMedGoogle Scholar
  • 21 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Inter Med 1993; 153: 1441-1447
    CrossrefPubMedGoogle Scholar
  • 22 Patel N, Ostrovsky D, Fish L, Nozzolillo E, Peterson A, Ansell J. Long-term patient self-monitoring and self-management of oral anticoagulation therapy with a capillary whole blood analyzer. Blood 1994; 84 (01) 69a Abstract
    PubMedGoogle Scholar
  • 23 Tripodi A, Arbini A, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio. Thromb Haemostas 1993; 70: 921-924
    PubMedGoogle Scholar